RentPath

ArrePath is an anti-infective drug discovery company focused on addressing the global challenge of antimicrobial resistance. The company utilizes a proprietary machine learning-based platform that analyzes pathogen behavior through high-content imaging to identify novel anti-infective agents with unique mechanisms of action. By combining world-class science in microbiology and microscopy with advanced AI/ML technologies, ArrePath aims to accelerate the discovery and development of differentiated small molecule therapeutics. The company's initial focus is on developing new classes of antibiotics to treat serious infections caused by resistant Gram-negative bacteria.